Altshuler Shaham LTD Vericel Corp Transaction History

Altshuler Shaham LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$46.35 - $59.75 $87,091 - $112,270	-1,879 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$47.2 - $67.81 $27,045 - $38,855	-573 Reduced 23.37%	1,879 $99,000
Q1 2021 May 13, 2021	SELL	$30.93 - $59.48 $31,734 - $61,026	-1,026 Reduced 29.5%	2,452 $136,000
Q4 2020 Feb 16, 2021	BUY	$18.53 - $31.5 $64,447 - $109,557	3,478 New	3,478 $107,000

291

50.8M

139K

68.5K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.69B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.